Ashley Hinson
Her campaign says she supports pharmacy-benefit-manager transparency, rural health-workforce investment, and expanded maternal and preventive care.
Back to the race record
Issue record
Health care
Campaign positions remain attributed. Official actions are shown separately, with narrow relationship labels and limits.
ADVERTISEMENT
Campaign positions
What each campaign says.
Josh Turek
His campaign says he supports protecting and expanding the Affordable Care Act, a public option, prescription-drug cost limits, and rural hospital and telehealth investment.
Thomas Laehn
No health-care position was found on the campaign issues page reviewed for this comparison.
ADVERTISEMENT
Evidence timeline
Where statements meet the record.
campaign position
Ashley Hinson: Not comparable yet
Her campaign says it will lower prescription drug costs by holding pharmacy benefit managers accountable. No bill among her 119th Congress sponsorships (33 bills and resolutions) or cosponsorships (237), nor among the 95 she sponsored and 924 she cosponsored across the 117th through 119th Congresses, listed on Congress.gov carries pharmacy benefit managers in its title. She cosponsored H.R. 8339, the Drug Origin Transparency Act of 2026 (April 16, 2026), whose official title describes a drug-manufacturing reporting bill rather than a price-transparency or pharmacy-benefit-manager bill, and H.R. 1492, which would equalize the Medicare negotiation period between small-molecule drugs and biologics (June 6, 2025); both were referred to committee. She sponsored H.R. 3878, the RNs for Rural Health Act of 2025 (June 10, 2025), which matches the rural-health-workforce plank. Limit: This check covers bill titles in the 117th through 119th Congresses; a pharmacy-benefit-manager provision inside a larger bill would not appear. H.R. 1492 concerns the timing of Medicare price negotiation and is not obviously in either direction of the plank; its text was not read for this card.
official action
Josh Turek: Matches stated record claim
His campaign says he sponsored legislation to cap insulin costs at $25 a month. He is the sole sponsor of H.F. 405 (2025), relating to insurance coverage for prescription insulin drugs, introduced and referred to the Commerce Committee on February 13, 2025 with no further action, and of H.F. 502 (2023) on the same subject. Limit: The $25 figure is the campaign's description; the bill text was not read for this card. Neither bill was enacted. No public post on this topic appears in the collected packet, so the card carries no dated earlier words.
official action
Josh Turek: Record does not bear out the claim
His campaign says he wrote and passed a right-to-repair bill for wheelchairs and mobility devices under Medicaid. He is the sole sponsor of H.F. 2194 (2024), which would have barred the Medicaid program from requiring a prescription or prior authorization to reimburse a provider for repairing complex rehabilitation technology already prescribed and paid for under Medicaid; a House subcommittee recommended passage 3-0 on February 1, 2024, and the bill received no further action and did not become law. A bill with the same title that he did not sponsor, H.F. 2706, barring a prescription or a face-to-face visit rather than prior authorization, was introduced by the House Ways and Means Committee as successor to House Study Bill 744, was floor-managed by Rep. Best of Carroll, and passed the House 91-0 on April 19, 2024, the final day of the session, with Turek among the ayes; the Senate referred it to committee that day and took no further action, so it also did not become law. He filed his own bill again, word for word, as H.F. 425 (2025), which was referred to committee and went no further, and none of the 105 bills and resolutions the Legislature lists for him as sponsor or floor manager in the 90th and 91st General Assemblies was enacted on this subject. The report the campaign cites for the claim, an August 13, 2024 Iowa Capital Dispatch article, says the Iowa Department of Health and Human Services dropped the prescription and in-person visit requirements by a policy change beginning July 1, 2024, after the legislation did not advance, and quotes him: “ultimately we weren’t able to get it across the finish line legislatively, but because of the attention that we brought to it and the advocacy that we did, we’re able to get it done.” Limit: The change the campaign points to did happen, by agency policy rather than by passage of a bill; this card tests the words “wrote and passed,” not the outcome or his part in prompting it. The check reads who the official record names as a bill’s sponsor and floor manager, so it cannot show who drafted language a committee introduces under its own name: H.F. 2706 carries the Ways and Means Committee’s name and nearly his bill’s words, and the record does not say whose drafting it was. Language folded into another member’s bill or into an amendment would likewise not appear. The article’s account of what prompted the agency is his and is not verified here. The article blocks automated readers and was read by the editor on September 8, 2026.
See something wrong or incomplete? Report it for review.
ADVERTISEMENT